C O L L E G E O F N U R S I N G · A D VA N C E D P R AC T I C E N U R S I N G
M I D T E R M E X A M I N AT I O N
N R 5 4 6 · We e k 4 · R e vi s e d E d i ti o n
Advanced Psychopharmacology for the
Psychiatric-Mental Health Nurse
Practitioner
Comprehensive Psychopharmacology & Advanced Clinical
Application with Verified Rationales
COUR S E NR 546 / NR546
EXAM T YP E Midterm — Week 4
T OTAL QUES T I ONS 75 Multiple-Choice Items
COGNI T I VE MI X 30% Recall / 50% Application / 20%
Analysis
P R OGR AM PMHNP — MSN / DNP Track
A + G U A R A N T E E · 100% VERIFIED ANSWERS ·
LATEST EDITION
2 0 2 6 — 2 0 2 7 AC A D E M I C Y E A R
,NR 546 — MIDTERM EXAM (WEEK 4) Advanced Psychopharmacology · 2026/2027 Edition
NR 546 / NR546 Midterm Exam — Week 4
Tested Questions with Revised Answers · Latest · A+ Guarantee
Instructions: This exam contains 75 multiple-choice questions distributed across six (6) sections. Each question has one
(1) correct answer marked [CORRECT]. Cognitive level distribution: 30% Recall, 50% Application, 20% Analysis. A
detailed rationale with advanced psychopharmacology clinical reasoning follows each question. Topics span neurobiology,
pharmacokinetics, antidepressants, mood stabilizers, anxiolytics, and integrated clinical scenarios aligned with
Chamberlain University NR 546 Week 4 blueprint and PMHNP certification competencies.
SECTION 1 — Neurobiology and Neurotransmission
Neuronal Structure · Synaptic Transmission · Neurotransmitter Systems · Q1–Q12
Q1: A PMHNP student is reviewing the cellular architecture of the neuron for an upcoming NR 546
midterm. Which neuronal structure contains the nucleus and integrates incoming signals from multiple
dendrites before generating an action potential?
A. Axon hillock
B. Soma (cell body) [CORRECT]
C. Axon terminal
D. Nodes of Ranvier
Correct Answer: B (Soma (cell body))
Rationale:
The soma (cell body) contains the nucleus and integrates excitatory and inhibitory postsynaptic potentials received from
dendrites; once threshold is reached at the axon hillock, an action potential is initiated. The axon terminal releases
neurotransmitter, and Nodes of Ranvier facilitate saltatory conduction along myelinated axons but do not integrate signals.
Q2: A 32-year-old patient is prescribed a medication that enhances GABA-A receptor function. The
PMHNP explains that GABA is the major inhibitory neurotransmitter in the CNS. Which ion channel
mechanism is directly responsible for the inhibitory effect produced when GABA binds its receptor?
A. Sodium influx causing depolarization
B. Calcium influx triggering vesicle fusion
C. Chloride influx causing hyperpolarization [CORRECT]
D. Potassium efflux causing excitation
Correct Answer: C (Chloride influx causing hyperpolarization)
Rationale:
The GABA-A receptor is a ligand-gated chloride channel; binding of GABA opens the channel and allows Cl- influx,
hyperpolarizing the postsynaptic membrane and reducing neuronal excitability. Sodium influx depolarizes, calcium influx
triggers neurotransmitter release at the presynaptic terminal, and chloride influx (not potassium efflux) is the dominant
inhibitory mechanism targeted by benzodiazepines and barbiturates.
Chamberlain University · PMHNP Program · A+ Guaranteed Verified Edition Page 2
, NR 546 — MIDTERM EXAM (WEEK 4) Advanced Psychopharmacology · 2026/2027 Edition
Q3: A patient with Parkinson disease shows degeneration of the nigrostriatal pathway. The PMHNP
recognizes that this dopamine pathway projects from the substantia nigra to the striatum and is primarily
responsible for which function?
A. Reward, pleasure, and addiction
B. Executive function and cognition
C. Motor control [CORRECT]
D. Prolactin inhibition
Correct Answer: C (Motor control)
Rationale:
The nigrostriatal pathway (substantia nigra pars compacta to dorsal striatum) modulates involuntary and voluntary motor
control; its degeneration produces the bradykinesia, rigidity, and resting tremor of Parkinson disease. Reward and addiction
map to the mesolimbic pathway (VTA to nucleus accumbens), executive function to mesocortical (VTA to prefrontal cortex),
and prolactin inhibition to the tuberoinfundibular pathway.
Q4: An NR 546 student is studying the serotonergic system. Which serotonin receptor functions as a
somatodendritic autoreceptor on raphe neurons, inhibiting further serotonin release when synaptic 5-HT
concentrations rise?
A. 5-HT1A [CORRECT]
B. 5-HT2A
C. 5-HT2C
D. 5-HT3
Correct Answer: A (5-HT1A)
Rationale:
5-HT1A autoreceptors located on the soma and dendrites of raphe neurons sense extracellular serotonin and reduce neuronal
firing via Gi-coupled inhibition of adenylyl cyclase; this negative feedback limits serotonergic tone. 5-HT2A mediates
psychedelic/perceptual effects, 5-HT2C modulates appetite (and is targeted by agonists like lorcaserin), and 5-HT3 is a
ligand-gated cation channel responsible for nausea and emesis (targeted by ondansetron).
Q5: A patient is started on an antipsychotic that acts as a D2 antagonist. The PMHNP understands that
D2-like receptors are Gi-coupled and inhibitory. Which receptor group is correctly classified as D1-like
(excitatory, Gs-coupled)?
A. D2 and D3
B. D1 and D5 [CORRECT]
C. D2 and D4
D. D3 and D4
Correct Answer: B (D1 and D5)
Rationale:
D1-like receptors (D1 and D5) couple to Gs, stimulate adenylyl cyclase, increase cAMP, and are generally excitatory on
direct-pathway medium spiny neurons. D2-like receptors (D2, D3, D4) couple to Gi, inhibit adenylyl cyclase, and are
inhibitory on indirect-pathway neurons; D2 blockade underlies both antipsychotic efficacy and parkinsonian/eps side effects.
Chamberlain University · PMHNP Program · A+ Guaranteed Verified Edition Page 3